{"id":26100,"date":"2026-06-15T05:11:13","date_gmt":"2026-06-15T05:11:13","guid":{"rendered":"https:\/\/www.fyeo.in\/ultragenic\/?p=26100"},"modified":"2026-06-15T06:01:04","modified_gmt":"2026-06-15T06:01:04","slug":"ultragenics-responsible-use-of-ai-in-gxp","status":"publish","type":"post","link":"https:\/\/www.fyeo.in\/ultragenic\/ultragenics-responsible-use-of-ai-in-gxp\/","title":{"rendered":"Ultragenic\u2019s responsible use of AI in GxP"},"content":{"rendered":"<section class=\"vc_row wpb_row vc_row-fluid  vc_custom_1578731244985\"><div class=\"wpb_column vc_column_container  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><div class=\"last-paragraph-no-margin\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-700\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-24108\" src=\"https:\/\/www.fyeo.in\/ultragenic\/wp-content\/uploads\/2026\/06\/Ultragenic-Blog-Responsible-AI-in-Pharmacovigilance.jpg\" alt=\"\" \/><\/h6>\n<p>At Ultragenic, <strong><em>we see AI fundamentally reshaping pharmacovigilance<\/em><\/strong> \u2014 from automated case intake to intelligent intake\/reporting workflows and modern safety systems. However, <strong>in GxP <\/strong><strong>\u2011regulated environments, innovation can never stand alone. <\/strong><\/p>\n<p>It must be firmly anchored in patient safety, data integrity, and regulatory compliance.<\/p>\n<p>For us, Responsible AI in pharmacovigilance goes far beyond deploying algorithms. It requires robust AI governance that is fully aligned with QMS, CAPA, and change control frameworks, ensuring AI remains inspection\u2011ready throughout its lifecycle.<\/p>\n<p><strong>At Ultragenic, this translates into:<\/strong><\/p>\n<ul class=\"list-text\">\n<li>Risk\u2011based validation proportionate to GxP impact<\/li>\n<li>Continuous lifecycle monitoring to proactively manage model drift<\/li>\n<li>Transparency and explainability to support regulatory inspections<\/li>\n<li>Human oversight, ensuring expert judgment remains central to all critical decisions<\/li>\n<\/ul>\n<p>Industry guidance consistently reinforces what we practice at Ultragenic: trust in AI is earned through disciplined governance and validation <strong>\u2014 not speed of adoption.<\/strong><\/p>\n<\/div>[vc_images_carousel images=&#8221;26121,26122,26123,26124,26125,26118,26119,26120&#8243; img_size=&#8221;full&#8221; onclick=&#8221;link_no&#8221; autoplay=&#8221;yes&#8221; hide_pagination_control=&#8221;yes&#8221; wrap=&#8221;yes&#8221;]<div class=\"separator-line-horrizontal-full bg-extra-light-gray center-col pofo-separator  vc_custom_1776427187177\" style=\"background-color:#ededed; min-height: 1px; width: 100%;\"><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"At Ultragenic, we see AI fundamentally reshaping pharmacovigilance \u2014 from automated case intake to intelligent intake\/reporting workflows and modern safety systems. However, in GxP \u2011regulated environments, innovation can never stand alone. It must be firmly anchored in patient safety, data integrity, and regulatory compliance. For us, Responsible AI in pharmacovigilance goes far beyond deploying algorithms. It requires robust AI governance that is fully aligned with QMS, CAPA, and change control frameworks, ensuring AI remains inspection\u2011ready throughout its lifecycle. At Ultragenic, this translates into: Risk\u2011based validation proportionate to GxP impact Continuous lifecycle monitoring to proactively manage model drift Transparency and explainability to support regulatory inspections Human oversight, ensuring expert judgment remains central to all critical decisions Industry guidance consistently reinforces what we practice at Ultragenic: trust in AI is earned through disciplined governance and validation \u2014 not speed of adoption. [vc_images_carousel images=\"26121,26122,26123,26124,26125,26118,26119,26120\" img_size=\"full\" onclick=\"link_no\" autoplay=\"yes\" hide_pagination_control=\"yes\" wrap=\"yes\"]","protected":false},"author":28,"featured_media":26103,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[89],"tags":[],"class_list":["post-26100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs"],"_links":{"self":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/26100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/comments?post=26100"}],"version-history":[{"count":9,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/26100\/revisions"}],"predecessor-version":[{"id":26126,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/26100\/revisions\/26126"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/media\/26103"}],"wp:attachment":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/media?parent=26100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/categories?post=26100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/tags?post=26100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}